CIK 0000920148 · Large accelerated filer
LABCORP HOLDINGS INC.
Sign in to watch- Ticker
- LH
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 992588107
- Phone
- 3362291127
- Business address
- 358 S MAIN ST, BURLINGTON, NC, 27215
- Former names
- LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,195,768
- in 4 filings, $1.1M under 10b5-1 plans
Net −$2,195,768. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-07 | Schechter Adam H President & CEO | Option exercise · Restricted Stock Unit | −3,249 | 15,430 | ||
| 2026-02-07 | Wilkinson Peter J SVP, Chief Accounting Officer | Option exercise | +134 | 2,074.22 | ||
| 2026-02-07 | Wilkinson Peter J SVP, Chief Accounting Officer | Option exercise · Restricted Stock Unit | −134 | 2,224 | ||
| 2026-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise | +517 | 5,981.14 | ||
| 2026-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise | +164 | 6,145.14 | ||
| 2026-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise · Restricted Stock Unit | −517 | 3,328 | ||
| 2026-02-07 | Schroeder Mark S EVP, Pres Diagnostics & COO | Option exercise · Restricted Stock Unit | −164 | 3,164 | ||
| 2026-02-07 | van der Vaart Sandra D EVP, Corporate Affairs | Option exercise | +353 | 2,942.49 | ||
| 2026-02-07 | van der Vaart Sandra D EVP, Corporate Affairs | Option exercise · Restricted Stock Unit | −353 | 1,517 | ||
| 2026-02-07 | Vaughn Bryan T EVP, Diagnostics | Option exercise | +178 | 5,443.57 | ||
| 2026-02-07 | Vaughn Bryan T EVP, Diagnostics | Option exercise · Restricted Stock Unit | −178 | 3,624 | ||
| 2026-02-07 | Meltzer Jonathan C EVP, Operations | Option exercise 10b5-1 | +263 | 2,957.33 | ||
| 2026-02-07 | Meltzer Jonathan C EVP, Operations | Option exercise · Restricted Stock Unit 10b5-1 | −263 | 2,317 | ||
| 2026-02-07 | Kyle Kathryn W EVP, Chief Legal Officer | Option exercise | +178 | 3,349.46 | ||
| 2026-02-07 | Kyle Kathryn W EVP, Chief Legal Officer | Option exercise · Restricted Stock Unit | −178 | 1,600 | ||
| 2026-02-07 | GRAHAM ANITA Z EVP, CHRO | Option exercise | +367 | 1,325 | ||
| 2026-02-07 | GRAHAM ANITA Z EVP, CHRO | Option exercise · Restricted Stock Unit | −367 | 1,397 | ||
| 2026-02-07 | Summy Amy B. EVP, Chief Marketing Officer | Option exercise | +222 | 5,654.5 | ||
| 2026-02-07 | Summy Amy B. EVP, Chief Marketing Officer | Option exercise · Restricted Stock Unit | −222 | 914 | ||
| 2026-02-07 | Bailey Megan D. EVP, Pres, Central Labs & Intl | Option exercise | +222 | 3,924 |
Page 10 of 14 · 262 trades